In 2024, the Center for Drug Evaluation of the National Medical Products Administration (NMPA) in China approved ** New Drug Applications (NDA) for innovative drugs, with * approvals granted to chemical drugs. A New Drug Application (NDA) is the mechanism through which pharmaceutical manufacturers propose that the regulatory body approve a new drug or biopharmaceutical for general use and sale.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
National Medical Products Administration. (March 18, 2025). Number of New Drug Applications (NDA) for innovative drugs granted approval in China from 2018 to 2024, by drug type [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 04, 2026, from /statistics/1319953/china-number-of-new-drug-applications-of-innovative-drugs-approved/
National Medical Products Administration. "Number of New Drug Applications (NDA) for innovative drugs granted approval in China from 2018 to 2024, by drug type." Chart. March 18, 2025. ÌÇÐÄÆƽâ°æ. Accessed August 04, 2026. /statistics/1319953/china-number-of-new-drug-applications-of-innovative-drugs-approved/
National Medical Products Administration. (2025). Number of New Drug Applications (NDA) for innovative drugs granted approval in China from 2018 to 2024, by drug type. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 04, 2026. /statistics/1319953/china-number-of-new-drug-applications-of-innovative-drugs-approved/
National Medical Products Administration. "Number of New Drug Applications (Nda) for Innovative Drugs Granted Approval in China from 2018 to 2024, by Drug Type." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 18 Mar 2025, /statistics/1319953/china-number-of-new-drug-applications-of-innovative-drugs-approved/
National Medical Products Administration, Number of New Drug Applications (NDA) for innovative drugs granted approval in China from 2018 to 2024, by drug type ÌÇÐÄÆƽâ°æ, /statistics/1319953/china-number-of-new-drug-applications-of-innovative-drugs-approved/ (last visited August 04, 2026)
Number of New Drug Applications (NDA) for innovative drugs granted approval in China from 2018 to 2024, by drug type [Graph], National Medical Products Administration, March 18, 2025. [Online]. Available: /statistics/1319953/china-number-of-new-drug-applications-of-innovative-drugs-approved/
